Department of Medicine Archive — Page 57 of 119
-
September 16, 2021
Structural variants in breast cancer risk genes
Vanderbilt epidemiologists conducted in-depth whole genome sequencing of breast cancer risk genes in Black women, who die at higher rates and have more aggressive disease, to discover mutations that may improve testing and treatment selection. -
September 16, 2021
Chung receives early investigator award from ASCPT
Vanderbilt's Cecilia Chung, MD, MPH, has received the 2022 Leon I. Goldberg Early Investigator Award from the American Society of Clinical Pharmacology and Therapeutics (ASCPT). -
September 10, 2021
Novel immunotherapy shows robust response for multiple myeloma
Vanderbilt research found that a novel immunotherapy demonstrated robust effectiveness in treating relapsed or refractory multiple myeloma. -
September 8, 2021
New Clinician Spotlight: Jane Freedman
Jane Freedman, MD, has joined Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and physician-in-chief of the Vanderbilt Heart and Vascular Institute. -
September 7, 2021
Regulators of fat cell metabolism
Vanderbilt researchers have discovered new details of the regulation of fat cell metabolism, findings that are important for combating obesity. -
September 6, 2021
Medical diagnoses in musicians
Vanderbilt researchers mined electronic health records to find medical diagnoses that are more or less prevalent among musicians, who are present in large numbers in “Music City.” -
September 2, 2021
Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients
Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.